65 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
Knowledge threatened, (i) relating to any injury to person or property or as a result of ownership, possession, provision or use of the Product or (ii … of any injury as a result of the use of the Product.
(d) During the last three years, there have been no material recalls, field notifications, field
8-K
CHRS
Coherus Biosciences Inc
26 Dec 23
Other Events
8:49pm
and well-tolerated adhesive. After the dose is administered, the needle automatically retracts, which reduces the risk of needlestick injury.
The approval
424B3
ctwzcdw1m xz
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
3g5ji
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
970z7mpo
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
2qvqugiug5k0qvsjz
16 Jun 23
Business combination disclosure
8:08am
425
fj9x6ru 83o
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
v8mjm4zdb5g ydh
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-10.1
wi7qvnshkdtn4k
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am